Publications by authors named "Jonathan Miksch"

Claim this Profile
U
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.
Madeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, Laya Rahbar Nikoukar, Michael Schäfers, Jonathan Miksch

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.
Jonathan Miksch, Elham Yousefzadeh-Nowshahr, Deni Hardiansyah, Gerhard Glatting, Christoph Solbach

Nuklearmedizin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry.
Madeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, Caner Civan, Ralph A Bundschuh, Jonathan Miksch

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Erratum to: Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer].
Anna-Sophie Strauß, Christian Bolenz, Ambros J Beer, Friedemann Zengerling, Meinrad Beer, Jonathan Miksch

Urologie· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer].
Anna-Sophie Strauß, Christian Bolenz, Ambros J Beer, Friedemann Zengerling, Meinrad Beer, Jonathan Miksch

Urologie· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, Andrea Farolfi, Francesca Serani, Jonathan Miksch

Radiother Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225.
Catherine Meyer, Vikas Prasad, Andreea Stuparu, Peter Kletting, Gerhard Glatting, Jonathan Miksch

EJNMMI Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy.
Constantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, Andrea Farolfi, Francesca Serani, Jonathan Miksch

Int J Radiat Oncol Biol Phys· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes of Radiation Treatment Concept Based on Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy.
Dirk Bottke, Jonathan Miksch, Reinhard Thamm, Thomas Krohn, Detlef Bartkowiak

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interobserver variability, detection rate, and lesion patterns of Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy.
Jonathan Miksch, Dirk Bottke, Thomas Krohn, Reinhard Thamm, Detlef Bartkowiak

Eur J Nucl Med Mol Imaging· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis